Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Sinopharm Group Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

21 Mar 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - SINOPHARM GROUP CO LTD (1099-HK)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 Mar 2015 Thomson Reuters Stock Report 11 $25.00

ValuEngine Industry Report for Large CAP Pharma(SHTDF)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

27 Mar 2015 ValuEngine, Inc. 10 $49.00

Sinopharm Group Co. Ltd. (1099) - Financial and Strategic SWOT Analysis Review

Sinopharm Group Co. Ltd. (1099) - Financial and Strategic SWOT Analysis Review Summary Sinopharm Group Co. Ltd. (Sinopharm) i...

03 Mar 2015 GlobalData 40 $125.00

SINOPHARM HOLDING CO LTD: Upgraded to Average

16 Feb 2015 Sadif Analytics Prime 3 $10.00

Wright Investors Service Comprehensive Report for Sinopharm Group Co Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

08 Feb 2015 Wright Reports 55 $75.00

Is SINOPHARM HOLDING CO LTD the Safe Haven Investors Seek?

03 Feb 2015 Sadif Analytics Prime 12 $25.00

The Portfolio Strategist : Issue 9 – Buying into the China Reform Dividend

*Hong Kong: The performance of Hong Kong listed equities has been disappointing vs. the performance of the S&P and the Shangh...

22 Jan 2015 Sun Hung Kai Financial 19 $173.00

Sinopharm Group Co. Ltd. (1099) - Financial and Strategic SWOT Analysis Review

Sinopharm Group Co. Ltd. (1099) - Financial and Strategic SWOT Analysis Review Summary Sinopharm Group Co. Ltd. (Sinopharm) i...

07 Nov 2014 GlobalData 40 $125.00

SINOPHARM HOLDING CO LTD: Downgraded to Risky

28 Oct 2014 Sadif Analytics Prime 3 $10.00